Portfolio company
Ariz Precision Medicine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops targeted nanoparticle and siRNA therapies for cancer patients and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ARase Therapeutics
This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.
Altamira Therapeutics
This company develops peptide-based nanoparticle technologies for RNA delivery to pharmaceutical industry partners developing treatments for cancer and inflammatory diseases.
Ayuvant
The company develops RNA nanoparticle immunotherapies to treat cancer patients who do not respond to existing immune checkpoint inhibitors.
Araris Biotech
This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.
OncoPrecision
The company develops patient-derived micro-avatar models and therapeutic antibodies to provide oncology drug discovery and precision medicine services for pharmaceutical partners and clinicians.
Avistone Pharmaceuticals
The company develops and manufactures precision oncology medicines, specifically small-molecule targeted therapies for patients with lung cancer and other solid tumours.
RS Research
This biotechnology company develops targeted nanomedicine delivery platforms and polymer-drug conjugates for oncology patients and pharmaceutical researchers.
Acrivon Therapeutics
This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.
